10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

________________

Form 10-Q

(Mark One)
☑	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.
For the quarterly period ended September 30, 2017
☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.
For the transition period from ____ to _____

 Commission file number: 1-16525

CVD EQUIPMENT CORPORATION

(Exact Name of Registrant as specified in its charter)

New York	11-2621692
(State or Other Jurisdiction of	(I.R.S. Employer Identification No.)
Incorporation or Organization)

355 South Technology Drive

Central Islip, New York 11722

(Address of principal executive offices)

(631) 981-7081
(Registrant’s telephone number, including area code)

Indicate by check whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes ☑ No☐

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (Section 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).                                

Yes ☑ No☐

Indicate by check mark whether registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act).

Large accelerated filer ☐	Accelerated filer ☐
Non-accelerated filer ☐	Smaller reporting company ☑	Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13 (a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes ☐ No ☑

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date: 6,409,891 shares of Common Stock, $0.01 par value at November 7, 2017.

CVD EQUIPMENT CORPORATION AND SUBSIDIARY

Index

Part I -	Financial Information
	Item 1 Financial Statements (Unaudited)
	Consolidated Balance Sheets at September 30, 2017 and December 31, 2016	3
	Consolidated Statements of Operations for the three and nine months ended September 30, 2017 and 2016	4
	Consolidated Statements of Cash Flows for the nine months ended September 30, 2017 and 2016	5
	Notes to Unaudited Consolidated Financial Statements	6
	Item 2 Management's Discussion and Analysis of Financial Condition and Results of Operations	15
	Item 3 Quantitative and Qualitative Disclosures About Market Risk	22
	Item 4 Controls and Procedures	22
Part II -	Other Information	24
	Item 1 Legal Proceedings.	24
	Item 2 Unregistered Sales of Equity Securities and Use of Proceeds.	24
	Item 3 Defaults Upon Senior Securities.	24
	Item 4 Mine Safety Disclosures.	24
	Item 5 Other Information.	24
	Item 6 Exhibits.	24
Signatures		26
Exhibit Index		27

2

PART 1 – FINANCIAL INFORMATION

CVD EQUIPMENT CORPORATION AND SUBSIDIARIES

Consolidated Balance Sheets

(Unaudited)

	September 30, 2017		December 31, 2016
ASSETS
Current Assets:
Cash and cash equivalents	$	17,180,657	$	21,677,186
Accounts receivable, net		4,057,354		607,522
Costs and estimated earnings in excess of billings on contracts in progress		4,457,926		2,596,518
Inventories		3,023,009		3,286,539
Other current assets		438,191		235,537
Total Current Assets		29,157,137		28,403,302
Property, plant and equipment, net		13,963,806		14,344,924
Construction in progress		160,263		94,058
Deferred income taxes – non-current		1,881,211		2,440,334
Other assets		415,828		68,450
Intangible assets, net		225,138		253,624
Total Assets	$	45,803,383	$	45,604,692
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current Liabilities:
Accounts payable	$	750,718	$	743,132
Accrued expenses		2,607,937		1,942,818
Current maturities of long-term debt		300,000		300,000
Billings in excess of costs and estimated earnings on contracts in progress		215,902		5,262,339
Deferred revenue		498,597		77,633
Total Current Liabilities		4,373,154		8,325,922
Long-term debt, net of current portion		2,740,508		2,965,508
Total Liabilities		7,113,662		11,291,430
Commitments and Contingencies		----		----
Stockholders’ Equity
Common stock - $0.01 par value – 20,000,000 shares authorized; issued and outstanding, 6,390,848 at September 30, 2017 and 6,346,590 at December 31, 2016		63,908		63.466
Additional paid-in-capital		24,830,704		24.131.474
Retained earnings		13,795,109		10,118.322
Total Stockholders’ Equity		38,689,721		34.313.262
Total Liabilities and Stockholders’ Equity	$	45,803,383	$	45.604.692

The accompanying notes are an integral part of these consolidated financial statement

3

CVD EQUIPMENT CORPORATION AND SUBSIDIARIES

Consolidated Statements of Operations

(Unaudited)

	Three Months Ended						Nine Months Ended
	September 30,						September 30,
	2017			2016			2017			2016
Revenue	$	10,831,729		$	4,883,511		$	31,312,055		$	13,630,726
Cost of revenue		6,229,062			3,192,345			18,127,799			9,912,207
Gross profit		4,602,667			1,691,166			13,184,256			3,718,519
Operating expenses
Research and development		158,310			150,257			339,610			304,591
Selling and shipping		345,406			261,006			983,731			805,681
General and administrative		2,208,628			1,675,163			6,423,016			5,145,343
Gain on settlement		---			---			---			(628,905	)
Total operating expenses		2,712,344			2,086,426			7,746,357			5,626,710
Operating income/(loss)		1,890,323			(395,260	)		5,437,899			(1,908,191	)
Other income (expense)
Interest income		28,485			7,054			54,538			20,582
Interest expense		(17,189	)		(19,153	)		(52,433	)		(61,608	)
Other income		2,575			118,645			3,014			123,093
Total other income		13,871			106,546			5,119			82,067
Income/(loss) before income taxes		1,904,194			(288,714	)		5,443,018			(1,826,124	)
Income tax expense/(benefit)		508,316			(203,310	)		1,766,231			(907,372	)
Net income/(loss)	$	1,395,878		$	(85,404	)	$	3,676,787		$	(918,752	)
Basic income/(loss) per common share	$	0.22		$	(0.01	)	$	0.58		$	(0.15	)
Diluted income/(loss) per common share	$	0.22		$	(0.01	)	$	0.58		$	(0.15	)
Weighted average common shares Outstanding-basic		6,378,656			6,323,039			6,314,224			6,269,102
Net effect of potential common share issuance:
Stock options		34,410			---			33,748			---
Weighted average common shares Outstanding-diluted		6,413,066			6,323,039			6,347,972			6,269,102

The accompanying notes are an integral part of these consolidated financial statements

4

CVD EQUIPMENT CORPORATION AND SUBSIDIARIES

Consolidated Statements of Cash Flows

(Unaudited)

	Nine Months Ended
	September 30,
	2017			2016
Cash flows from operating activities:
Net income/(loss)	$	3,676,787		$	(918,752	)
Adjustments to reconcile net income/(loss) to net cash provided by operating activities:
Stock-based compensation expense		677,552			544,238
Depreciation and amortization		623,656			618,227
Deferred tax expense/(benefit)		559,123			(836,615	)
Provision for doubtful accounts		3,724			39,313
Changes in operating assets and liabilities:
Accounts receivable		(3,453,556	)		(4,108,505	)
Costs and estimated earnings in excess of billings on contracts in progress		(1,861,408	)		1,475,190
Inventories		263,531			(64,328	)
Other current assets		(195,073	)		(22,669	)
Increases/(decreases) in operating liabilities:
Accounts payable and accrued expenses		665,119			(2,251,405	)
Current maturities of long-term debt		---			(280,000	)
Billings in excess of costs and estimated earningson contracts in progress		(5,046,437	)		9,130,870
Deferred revenue		420,965			(158,031	)
Total adjustments		(7,342,804	)		4,086,285
Net cash (used in)/provided by operating activities		(3,666,017	)		3,167,533
Cash flows from investing activities:
Release of restricted cash		---			200,000
Capital expenditures		(618,505	)		(42,670	)
Deposits		(9,127	)		1,550
Net cash (used in)/provided by investing activities		(627,632	)		158,880
Cash flows from financing activities:
Net proceeds from stock options exercised		22,120			462,000
Payments of long-term debt		(225,000	)		(225,000	)
Net cash (used in)/provided by financing activities		(202,880	)		237,000
Net (decrease)/increase in cash and cash equivalents		(4,496,529	)		3,563,413
Cash and cash equivalents at beginning of period		21,677,186			13,073,331
Cash and cash equivalents at end of period	$	17,180,657		$	16,636,744
Supplemental disclosure of cash flow information:
Income taxes paid	$	701,800		$	101,352
Interest paid	$	52,433		$	61,608

The accompanying notes are an integral part of these consolidated financial statements

5

CVD EQUIPMENT CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

September 30, 2017

(Unaudited)

NOTE 1:     BASIS OF PRESENTATION

The accompanying unaudited consolidated financial statements for CVD Equipment Corporation and Subsidiaries (collectively, “the Company”) have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and with the instructions to Form 10-Q and Article 8 of Regulation S-X. They do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary in order to make the interim financials not misleading have been included and all such adjustments are of a normal recurring nature. The operating results for the three and nine months ended September 30, 2017 are not necessarily indicative of the results that can be expected for the year ending December 31, 2017.

The balance sheet as of December 31, 2016 has been derived from the audited consolidated financial statements at such date, but does not include all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements. For further information, please refer to the consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2016, filed with the Securities and Exchange Commission on March 30, 2017, including the accounting policies followed by the Company as set forth in Note 2 to the consolidated financial statements contained therein.

All material intercompany transactions have been eliminated in consolidation. In addition, certain reclassifications have been made to prior period consolidated financial statements to conform to the current year presentation.

NOTE 2:     SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Revenue Recognition

Revenues from product and service sales, including those based on time and materials type contracts, are recognized when persuasive evidence of an arrangement exists, product delivery has occurred or services have been rendered, pricing is fixed or determinable, and collection is reasonably assured. Service sales revenues, principally representing repair, maintenance and engineering activities are recognized over the contractual period or as services are rendered.

Revenues from fixed price contracts are recognized on the percentage of completion method, measured on the basis of incurred costs to estimated total costs for each contract. This “cost to cost” method is used because management considers it to be the best available measure of progress on these contracts.

6

CVD EQUIPMENT CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

September 30, 2017

(Unaudited)

NOTE 2:     SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)

Contract costs include all direct material and labor costs and those indirect costs related to contract performance, such as indirect labor, supplies, tools, repairs and depreciation costs.

Selling, general and administrative costs are charged to expense as incurred. Provisions for estimated losses on contracts in progress are made in the period in which such losses are determined. Changes in job requirements, job conditions, and estimated profitability, and final contract settlements may result in revisions to costs and income and are recognized in the period in which the revisions are determined.

The asset, “Costs and estimated earnings in excess of billings on contracts in progress,” represents revenues recognized in excess of amounts billed.

The liability, “Billings in excess of costs and estimated earnings on contracts in progress,” represents amounts billed in excess of revenues recognized.

Recent Accounting Pronouncements

In May 2014, The Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2014-09, “Revenue from Contracts with Customers” (Topic 606), which changes the criteria for recognizing revenue. The standard requires an entity which recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The standard requires a five-step process for recognizing revenues including identifying the contract with the customer, identifying the performance obligations in the contract, determining the transaction prices, allocating the transaction price to the performance obligations in the contract, and recognizing revenue when (or as) the entity satisfies a performance obligation. Because of the broad scope of this new standard, as it could impact the Company’s contract portfolio and therefore net sales and operating income as well as related business processes, the Company is continuing to perform its detailed review and evaluation of the operational impact of this new ASU including which transition approach to use and the overall effect on its current accounting policies and practices in order to identify potential differences that would result from applying the requirements of the new standard.

The Company believes there is no additional new accounting guidance adopted, but not yet effective that is relevant to the readers of its financial statements. However, there are numerous new proposals under development which, if and when enacted, may have significant impact on its financial reporting.

7

CVD EQUIPMENT CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

September 30, 2017

(Unaudited)

NOTE 3:     CONCENTRATION OF CREDIT RISK

Cash and cash equivalents

Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash and cash equivalents and accounts receivable. The Company places its cash equivalents with high credit-quality domestic financial institutions and invests its excess cash primarily in savings accounts and money market instruments. The Company performs periodic evaluations of the relative credit standing of all such institutions as it seeks to maintain stability and liquidity. Cash and cash investments at September 30, 2017 and December 31, 2016, exceeded the Federal Deposit Insurance Corporation (“FDIC”) limits by $15.6 million and $20.2 million respectively.

Sales concentration

Revenue to a single customer in any one period can exceed 10% of our total sales. During the three months ended September 30, 2017 and September 30, 2016, one customer represented approximately 59% and 43% respectively, of our revenues. During the nine months ended September 30, 2017 and September 30, 2016 that same customer represented 65% and 40% respectively, of our revenues.

Accounts receivable

The Company sells products and services to various companies across several industries in the ordinary course of business. The Company performs ongoing credit evaluations to assess the probability of accounts receivable collection based on a number of factors, including past transaction experience, evaluation of their credit history and review of the invoicing terms of the contract to determine the financial strength of its customers. The Company also maintains allowances for anticipated losses. One customer represented 23.2%, another customer represented 14.2% and a third customer represented 10.0% of the accounts receivable balance at September 30, 2017.

8

CVD EQUIPMENT CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

September 30, 2017

(Unaudited)

NOTE 4:     CONTRACTS IN PROGRESS

Costs and estimated earnings in excess of billings on contracts in progress are summarized as follows:

	September 30, 2017			December 31, 2016
Costs incurred on contracts in progress	$	11,557,916		$	4,678,192
Estimated earnings		19,302,951			10,733,826
		30,876,962			15,412,018
Less: Billings to date		26,634,938			(18,077,839	)
Included in accompanying balance sheets under the following captions:	$	4,242,024		$	(2,665,821	)
Costs and estimated earnings in excess of billings on contracts in progress	$	4,457,926		$	2,596,518
Billings in excess of costs and estimated earnings on contracts in progress		(215,902	)		(5,262,339	)
	$	4,242,024		$	(2,665,821	)

NOTE 5:     INVENTORIES

Inventories are stated at the lower of cost or net realizable value computed on a first-in, first-out basis and consist of the following:

	September 30, 2017		December 31, 2016
Raw materials	$	2,762,009	$	3,062,830
Work-in-process		234,023		159,482
Finished goods		26,977		64,227
Totals	$	3,023,009	$	3,286,539

9

CVD EQUIPMENT CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

September 30, 2017

(Unaudited)

NOTE 6:     ACCOUNTS RECEIVABLE

Accounts receivable are presented net of an allowance for doubtful accounts of approximately $6,000 and $2,000 as of September 30, 2017 and December 31, 2016, respectively. The allowance is based on prior experience and management’s evaluation of the collectability of accounts receivable. Management believes the allowance is adequate. However, future estimates may change based on changes in future economic conditions.

NOTE 7:     DEBT

The Company has a revolving credit facility with HSBC Bank, USA, N.A. (“HSBC”) providing up to $7 million, although the Company has never utilized this facility. This credit facility remains available until September 1, 2018. The credit facility also contains certain financial covenants, all of which the Company was in compliance with at September 30, 2017 and December 31, 2016.

The Company has a loan agreement with HSBC which is secured by a mortgage against its Central Islip facility. The loan is payable in 120 consecutive equal monthly installments of principal of $25,000 plus interest thereon and a final balloon payment upon maturity in March 2022. Interest accrues on the loan, at the Company’s option, at the variable rate of LIBOR plus 1.75% which was 2.99% and 2.52% at September 30, 2017 and December 31, 2016, respectively. The principal balances on the mortgage at September 30, 2017 and December 31, 2016 were approximately $3.0 and $3.3 million, respectively.

NOTE 8:     STOCK-BASED COMPENSATION EXPENSE

During the three and nine months ended September 30, 2017 and September 30, 2016, the Company recorded compensation expense as part of general administrative expense, of $242,000 and $198,000 and $678,000 and $544,000 respectively, for the cost of employee and director services received in exchange for equity instruments based on the grant-date fair value of those instruments.

10

CVD EQUIPMENT CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

September 30, 2017

(Unaudited)

NOTE 9:     INCOME TAXES

The provision for income taxes includes the following:

	Nine Months Ended September 30,
	2017		2016
Current:
Federal	$	1,195,528	$	(71,070	)
State		11,580		314
Total Current income tax provision/(benefit)		1,207,108		(70,756	)
Deferred:
Federal	$	559,123	$	(836,616	)
State		----		---
Total deferred income tax provision/(benefit)		559,123		(836,616	)
Income tax expense/(benefit)	$	1,766,231	$	(907,372	)

Tax Rate Reconciliation

The reconciliation between the Company’s effective tax rate on income from continuing operations and the statutory rate is as follows:

	Nine Months Ended
	September 30,
	2017			2016
Income tax benefit at federal statutory rate [34%]	$	2,075,004		$	(620,882	)
Change in other accruals		90,781			(216,640	)
Difference between tax and book depreciation		(201,847	)		50,213
Stock-based compensation		(197,707	)		(48,993	)
Provision for tax return true up		----			(71,070	)
Income tax expense	$	1,766,231		$	(907,372	)

11

CVD EQUIPMENT CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

September 30, 2017

(Unaudited)

NOTE 10:     EARNINGS PER SHARE

Basic earnings per share are computed by dividing net earnings available to common shareholders (the numerator) by the weighted average number of common shares (the denominator) for the period presented. The computation of diluted earnings per share is similar to basic earnings per share, except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potentially dilutive common shares had been issued.

Stock options to purchase 381,930 shares of common stock were outstanding and 196,930 were exercisable during the three and nine months ended September 30, 2017. Stock options to purchase 159,730 shares were outstanding and 79,730 were exercisable during the three and nine months ended September 30, 2016. For the three and nine months ended September 30, 2017, options to purchase 34,410 and 33,748 shares were included in the diluted earnings per share calculation respectively. The balance of stock options outstanding at September 30, 2017 were not included as their effect would have been anti-dilutive. For the three and nine months ended September 30, 2016, none of the outstanding options were included in the earnings per share calculation as their effect would have been antidilutive.

The potentially dilutive common shares from warrants and options are calculated in accordance with the treasury stock method, which assumes that proceeds from the exercise of all warrants and options are used to repurchase common stock at market value. The amount of shares remaining after the proceeds are exhausted represents the potential dilutive effect of the securities.

12

CVD EQUIPMENT CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

September 30, 2017

(Unaudited)

NOTE 11:     SEGMENT REPORTING

The Company operates through two (2) segments, CVD and SDC. The CVD division, which operates out of Central Islip, New York, is utilized for silicon, silicon germanium, silicon carbide and gallium arsenide processes. SDC is the Company’s ultra-high purity manufacturing division in Saugerties, New York. The respective accounting policies of CVD and SDC are the same as those described in the summary of significant accounting policies (see Note 2). The Company evaluates performance based on several factors, of which the primary financial measure is income or (loss) before taxes.

Three Months

Ended September 30,

	CVD			SDC			Eliminations *			Consolidated
2017
Assets	$	41,615,403		$	5,977,491		$	(1,789,511	)	$	45,803,383
Revenue	$	8,862,726		$	2,548,612		$	(579,609	)	$	10,831,729
Pretax income		1,055,683			848,511						1,904,194
2016
Assets	$	46,147,895		$	4,316,826		$	(2,960,808	)	$	47,503,913
Revenue	$	4,253,544		$	846,696		$	(216,729	)	$	4,883,511
Pretax income		(180,638	)		(108,076	)					(288,714	)
December 31, 2016
Assets	$	43,300,131		$	4,558,111		$	(2,253,550	)	$	45,604,692

Nine Months

Ended September 30,

	CVD			SDC			Eliminations *			Consolidated
2017
Revenue	$	26,847,732		$	6,360,762		$	(1,896,439	)	$	31,312,055
Pretax income		3,403,907			2,039,111						5,443,018
2016
Revenue	$	11,589,421		$	2,352,384		$	(311,079	)	$	13,630,726
Pretax (loss)		(1,544,278	)		(281,846	)					(1,826,124	)

*All elimination entries represent intersegment revenues eliminated in consolidation for external financial reporting.

13

CVD EQUIPMENT CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

September 30, 2017

(Unaudited)

Note 12:SUBSEQUENT EVENTS

On October 24, 2017, CVD Equipment Corporation (the “Company”) entered into an Agreement of Purchase and Sale (the “Agreement”) to purchase a building and real property located at 555 North Research Place, Central Islip, New York 11722 (the “Premises”) from Creative Bath Products, Inc. The purchase price for the Premises is $13,850,000.00, exclusive of closing costs (the “Purchase Price”). Upon execution of the Agreement, the Company deposited the sum of $500,000 into escrow as an initial down payment against the Purchase Price, with the remaining balance of $13,350,000.00 to be paid at the closing. The acquisition of the Premises and the consummation of the transactions contemplated by the Agreement are contingent upon, among other things, the Company obtaining a commitment from an Institutional Lender (as defined in the Agreement) to make a first mortgage loan to the Company of $10,387,500.00 on such terms and conditions as are specified in the Agreement. The anticipated closing date of the acquisition of the Premises and the transactions contemplated by the Agreement is on or about January 22, 2018, or such earlier date as the Company may direct upon three (3) days written notice and is subject to the satisfaction by the parties of customary closing conditions as described in the Agreement.

On October 31, 2017 (the “Closing Date”), CVD MesoScribe Technologies Corporation, a New York corporation (“Buyer”) and newly formed and wholly-owned indirect subsidiary of CVD Equipment Corporation (the “Company”) and MesoScribe Technologies, Inc., a Delaware corporation (“Seller”) entered into an Asset Purchase Agreement (the “Asset Purchase Agreement”). Pursuant to the Asset Purchase Agreement, among other things, Buyer acquired (the “Acquisition”) substantially all of the operating assets and business of the Seller (excluding cash, accounts receivable and other specified excluded assets), as more particularly described in the Asset Purchase Agreement.

Pursuant to the Asset Purchase Agreement, the purchase price for the assets acquired in the Acquisition was $800,000, of which $500,000 was paid on the Closing Date and $300,000 may be paid to Seller as additional contingent consideration based upon the achievement of certain revenue thresholds and other criteria set forth in the Asset Purchase Agreement with respect to each of the two (2) consecutive twelve (12) month measurement periods following the Closing Date.

The Asset Purchase Agreement contains usual and customary representations, warranties and covenants of the parties, as well as indemnification provisions.

14

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

Except for historical information contained herein, this “Management’s Discussion and Analysis of Financial Condition and Results of Operations” contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, as amended. These statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance, or achievements of the Company to be materially different from any future results, performance, or achievements expressed or implied by such forward-looking statements. These forward-looking statements were based on various factors and were derived utilizing numerous important assumptions and other important factors that could cause actual results to differ materially from those in the forward-looking statements. Important assumptions and other factors that could cause actual results to differ materially from those in the forward-looking statements, include but are not limited to: competition in the Company’s existing and potential future product lines of business; the Company’s ability to obtain financing on acceptable terms if and when needed; uncertainty as to the Company’s future profitability, uncertainty as to the future profitability of acquired businesses or product lines, uncertainty as to any future expansion of the Company. Other factors and assumptions not identified above were also involved in the derivation of these forward-looking statements and the failure of such assumptions to be realized as well as other factors may also cause actual results to differ materially from those projected. The Company assumes no obligation to update these forward looking statements to reflect actual results, changes in assumptions or changes in other factors affecting such forward-looking statements. Past results are no guaranty of future performance. You should not place undue reliance on any forward-looking statements, which speak only as of the dates they are made. When used with this Report, the words “believes,” “anticipates,” ”expects,” “estimates,” “plans,” “intends,” “will” and similar expressions are intended to identify forward-looking statements.

15

Results of Operations

Three Months Ended September 30, 2017 vs. Three Months Ended September 30, 2016

	Three Months Ended
	September 30, 2017			September 30, 2016			Change			% Change
(In thousands)
Revenue
CVD (net of eliminations)	$	8,833		$	4,254		$	4,579			107.6
SDC (net of eliminations)		1,999			630			1,369			217.3
Total Revenue		10,832			4,884			5,948			121.8
Cost of Goods Sold		6,229			3,192			3,037			95.1
Gross Profit		4,603			1,691			2,912			172.2
Gross Margin		42.5	%		34.6	%
Research and development		158			150			8			5.3
Selling and shipments		345			261			84			32.2
General and administrative		2,209			1,675			534			31.9
Total operating expenses		2,712			2,086			626			30.0
Operating income/(loss)		1,890			(395	)		2,285			578.5
Other income		14			106			(92	)		(86.8	)
Income/(loss) before taxes		1,904			(289	)		2,193			758.8
Income tax expense/(benefit)		508			(204	)		712			349.0
Net income/(loss)		1,396			(85	)		1,481			1,742.4

Revenue

Our revenue for the three months ended September 30, 2017 was $10.8 million compared to $4.9 million for the three months ended September 30, 2016, resulting in an increase of $5.9 million or 121.8%, which was primarily attributable to the work performed on the increase in orders received over the past 15 months. One customer in the aerospace industry represented approximately 59% and 43% of our revenue for the three months ended September 30, 2017 and September 30, 2016, respectively. We are continuing to receive additional follow-on business from that customer as well as receiving additional orders and opportunities with new and other current customers. The mix and type of customers, and sales to any single customer, may vary significantly from quarter to quarter and from year to year. If any of our significant customers do not place orders, or they substantially reduce, delay or cancel orders, we may not be able to replace the business in a timely manner or at all, which could have a material adverse effect on our results of operations and financial condition. The SDC division increased their revenue from third party customers to $2.0 million for the three months ended September 30, 2017, an increase of 217.3% compared to revenue of $630,000 for the three months ended September 30, 2016. The increase is primarily attributable to a significant order from one customer that comprised approximately 57% of the three month total.

16

Gross Profit

We generated a gross profit of $4.6 million with a gross profit margin of 42.5% for the three months ended September 30, 2017 compared to a gross profit of $1.7 million and a gross profit margin of 34.6% for the three months ended September 30, 2016. The increased gross profit and gross margin was the result of both greater overall revenue and the product mix of orders being worked on.

Research and Development, Selling, General and Administrative Expenses

Internal research and development expenses for the three months ended September 30, 2017 amounted to $158,000 compared to $150,000 for the three months ended September 30, 2016, as we increased the level of investment in research and development for our products.

Selling and shipping expenses for the three months ended September 30, 2017 was $345,000 compared to $261,000 for the three months ended September 30, 2016 which represented an increase of 32.2% which was primarily a result of additional personnel costs related to CVD Materials, including its recently established CVD Tantaline ApS subsidiary, during the current period.

We incurred approximately $2.2 million of general and administrative expenses or 20.4% of our revenue for the three months ended September 30, 2017 compared to approximately $1.7 million or 34.7% of our revenue during the three months ended September 30, 2016. This increase of 31.9% was primarily a result of additional personnel and occupancy costs related to CVD Materials, including its recently established CVD Tantaline ApS subsidiary, during the current period.

Operating income/(loss)

As a result of the increased revenues and higher gross margins, we achieved income from operations of $1.9 million for the three months ended September 30, 2017 compared to having incurred a loss from operations of $395,000 for the three months ended September 30, 2016.

Other income

During the three months ended September 30, 2017 our interest income exceeded our interest expense by $14,000. During the three months ended September 30, 2016, we received a payment from our insurance company on a property damage claim the exceeded the repair costs by $119,000, which was partially offset by our interest expense exceeding our interest income.

17

Income Taxes

We incurred an income tax expense of $508,000 for the three months ended September 30, 2017. For the three months ended September 30, 2016, we did not incur any current income tax expense and recorded $204,000 of deferred tax benefits primarily due to the tax loss that we incurred during the period.

Net income/(loss)

We reported net income of approximately $1.4 million or $0.22 per share basic and diluted for the three months ended September 30, 2017 compared to a net loss of $85,000 or ($0.01) per share basic and diluted for the three months ended September 30, 2016

18

Nine Months Ended September 30, 2017 vs. Nine Months Ended September 30, 2016

	September 30, 2017			September 30, 2016			Change			% Change
(In thousands)
Revenue
CVD (net of eliminations)	$	26,741		$	11,584		$	15,157			130.8
SDC (net of eliminations)		4,571			2,047			2,524			123.3
Total Revenue		31,312			13,631			17,681			129.7
Cost of Goods Sold		18,128			9,912			8,216			82.9
Gross Profit		13,184			3,719			9,465			95.5
Gross Margin		42.1	%		27.3	%
Research and development		339			305			34			11.1
Selling and shipping		984			806			178			22.1
General and administrative		6,423			5,145			1,276			24.8
Gain on settlement		---			(629	)		629
Total operating expenses		7,746			5,627			2,117			37.6
Operating income/(loss)		5,438			(1,908	)		7,346			385.0
Other income		5			82			(77	)		(93.9	)
Income/(loss) before taxes		5,443			(1,826	)		7,269			398.1
Income tax expense/(benefit)		1,766			(908	)		2,674			294.5
Net income/(loss)		3,677			(918	)		4,595			500.5

19

Revenue

Our revenue for the nine months ended September 30, 2017, totaled $31.3 million, an increase of $17.7 million or 129.7% compared to $13.6 million for the nine months ended September 30, 2016. This increase was primarily attributable to the work performed on the increase in orders received over the past 15 months. Our largest customer represented approximately 65% and 40% of our revenue for the nine months ended September 30, 2017 and September 30, 2016, respectively.

We are continuing to receive additional follow-on business from that customer as well as receiving additional orders and opportunities with new and other current customers. The mix and type of customers, and sales to any single customer, may vary significantly from quarter to quarter and from year to year. If any of our significant customers do not place orders, or they substantially reduce, delay or cancel orders, we may not be able to replace the business in a timely manner or at all, which could have a material adverse effect on our results of operations and financial condition.

Revenue from the SDC division for the nine months ended September 30, 2017 reached $4.6 million compared to $2.0 million for the nine months ended September 30, 2016 an increase of 123.3%. One customer accounted for approximately 29% of the total.

Gross Profit

During the nine months ended September 30, 2017, we generated a gross profit of $13.2 million resulting in a gross profit margin of 42.1% as compared to the nine months ended September 30, 2016 when our gross profit was $3.7 million with a gross profit margin of 27.3%. The increase in gross profit and gross margin was the result of a combination of greater overall revenue and product mix of orders being worked on.

Research and Development, Selling and General and Administrative Expenses

Internal research and development expenses for the nine months ended September 30, 2017 were $339,000 compared to $305,000 for the nine months ended September 30, 2016 as we begin to ramp our efforts of independently conducted research and development activities.

Selling and shipping expenses for the nine months ended September 30, 2017 and 2016 were $984,000 and $806,000, respectively, an increase of 22.1%, which was a result of the additional personnel costs associated with the start-up activity in CVD Materials.

General and administrative expenses totaled $6.4 million and $5.1 million for the nine months ended September 30, 2017 and 2016, respectively, an increase of $1.3 million or 24.8%. The increase is primarily attributable to the additional personnel and occupancy costs associated with the start-up activity in CVD Materials including its recently established CVD Tantaline ApS subsidiary.

Gain on Settlement

The Company has included in its financial statements for the nine months ended September 30, 2016, the results of a negotiated reduction to legal fees and expenses previously accrued in connection with the settlement of the Taiwan Glass litigation. The final negotiated sum was $1.1 million, resulting in a reduction of the amount that was previously billed and accrued and a gain on the statement of operations of $629,000 during the period.

20

Operating Income/(loss)

As a result of the increased revenues and higher gross margin, for the nine months ended September 30, 2017, we achieved operating income of $5.4 million compared to a loss from operations of $1.9 million for the nine months ended September 30, 2016.

Other Income

During the nine months ended September 30, 2017 our interest income exceeded our interest expense by $5,000. During the nine months ended September 30, 2016, we received a payment from our insurance company on a property damage claim the exceeded the repair costs by $119,000, which was partially offset by our interest expense exceeding our interest income.

Income Taxes

For the nine months ended September 30, 2017 we incurred current income tax expense of $1,207,000 and deferred income tax expense of $559,000 for an effective tax rate of 32.4% compared to the nine months ended September 30, 2016, when we did not incur any current income tax expense, received a refund of $71,000 as a result of an overpayment on the 2015 federal corporate tax return and recorded $837,000 of deferred tax benefits primarily due to the tax loss we incurred for the current period.

Net Income/(loss)

We reported net income of $3.7 million or $0.58 per share basic and diluted for the nine months ended September 30, 2017 compared to a net loss of $0.9 million or ($0.15) per share basic and diluted for the nine months ended September 30, 2016.

Inflation

Inflation has not materially impacted the operations of our Company.

Liquidity and Capital Resources

As of September 30, 2017 we had working capital of $24.8 million compared to $19.9 million at December 31, 2016, an increase of $4.9 million primarily as a result of an increase in accounts receivables and a reduction in the billing in excess of costs and estimated earnings on contracts in progress. This was partially offset by a decrease in cash and cash equivalents. As of September 30, 2017 our cash and cash equivalents were $17.2 million, compared to $21.7 million at December 31, 2015, a decrease of $4.5 million. This decrease was primarily the result of costs incurred and paid on orders currently being worked on that we have previously been paid.

Accounts receivable, net, as of September 30, 2017 and December 31, 2016 were $4.1 million and $0.6 million respectively. One customer represented 23.2%, another customer represented 14.2% and a third customer represented 10.0% of the accounts receivable balance at September 30, 2017.

21

At September 30, 2017, the number of full time employees increased to 204 employees compared to 173 at December 31, 2016.

We believe that our cash and cash equivalents position and cash flow from operations will be sufficient to meet our working capital and capital expenditure requirements for the next twelve months.

We may also raise additional funds in the event we determine in the future to effect one or more acquisitions of businesses, technologies or products. In addition, we may elect to raise additional funds even before we need them if the conditions for raising capital are favorable. Any equity or equity-linked financing could be dilutive to existing shareholders.

Off-Balance Sheet Arrangements.

We have no off-balance sheet arrangements at this time.

Item 3.          Quantitative and Qualitative Disclosures About Market Risk.

Not applicable.

Item 4.               Controls and Procedures.

Evaluation of Disclosure Controls and Procedures

We maintain a system of disclosure controls and procedures (as defined in Rule 13a-15(e) under the Exchange Act). As required by Rule 13a-15(b) under the Exchange Act, management of the Company, under the direction of our Chief Executive Officer and Chief Financial Officer, reviewed and performed an evaluation of the effectiveness of design and operation of the Company’s disclosure controls and procedures (as defined in Rule 13a-15(e) under the Exchange Act) as of the end of the period covered by this Quarterly Report on Form 10-Q (the “Report”).

Based on that review and evaluation, the Chief Executive Officer and Chief Financial Officer, along with our management, have determined that as of the end of the period covered by the Report on Form 10-Q, the disclosure controls and procedures were and are effective to provide reasonable assurance that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and were effective to provide reasonable assurance that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding disclosures.

Changes in Internal Controls

22

There were no changes in our internal controls over financial reporting as defined in Rule 13a-15(f) or Rule 15d-15(f) under the Exchange Act that occurred during the most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, the internal controls over financial reporting.

Limitations on the Effectiveness of Controls

We believe that a control system, no matter how well designed and operated, cannot provide absolute assurance that the objectives of the control systems are met, and no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within a company have been detected.

23

CVD EQUIPMENT CORPORATION

PART II

OTHER INFORMATION

Item 1.	Legal Proceedings.
	None.

Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds.
	None.

Item 3.	Defaults Upon Senior Securities.
	None.

Item 4.	Mine Safety Disclosures.
	Not Applicable.

Item 5.	Other Information.
	None.

Item 6.	Exhibits
	The exhibits below are hereby furnished to the SEC as part of this report:

31.1*	Certification of Leonard A. Rosenbaum, Chief Executive Officer, dated November 14, 2017.
31.2*	Certification of Glen R. Charles, Chief Financial Officer, dated November 14, 2017.
32.1*	Certification of Leonard A. Rosenbaum, Chief Executive Officer, dated November 14, 2017, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2*	Certification of Glen R. Charles, Chief Financial Officer, dated November 14, 2017, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes- Oxley Act of 2002.

24

101.INS**	XBRL Instance.
101.SCH**	XBRL Taxonomy Extension Schema.
101.CAL**	XBRL Taxonomy Extension Calculation
101.DEF**	XBRL Taxonomy Extension Definition.
101.LAB**	XBRL Taxonomy Extension Labels.
101.PRE**	XBRL Taxonomy Extension Presentation.

____________

● Filed herewith

**Pursuant to Rule 406T of Regulation S-T, these interactive data files are deemed not to be filed or part of a registration statement or prospectus for purposes of Section 11 or 12 of the Securities Act of 1933, as amended, are deemed not filed for purposes of Section 18 of the Securities Act of 1934, as amended, and otherwise not subject to liability under these sections.

25

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, this 14^th day of November 2017.

CVD EQUIPMENT CORPORATION
By:	/s/ Leonard A. Rosenbaum
	Leonard A. Rosenbaum
	Chief Executive Officer, President and Chairman
	(Principal Executive Officer)
By:	/s/ Glen R. Charles
	Glen R. Charles
	Chief Financial Officer
	(Principal Financial and
	Accounting Officer)

26

EXHIBIT INDEX

EXHIBIT NUMBER	DESCRIPTION
31.1*	Certification of Leonard A. Rosenbaum, Chief Executive Officer, dated November 14, 2017
31.2*	Certification of Glen R. Charles, Chief Financial Officer, Dated November 14, 2017
32.1*	Certification of Leonard A. Rosenbaum, Chief Executive Officer, dated November 14, 2017, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2*	Certification of Glen R. Charles, Chief Financial Officer,dated November 14, 2017 pursuant to 18 U.S.C.Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS**	XBRL Instance.
101.SCH**	XBRL Taxonomy Extension Schema.
101.CAL**	XBRL Taxonomy Extension Calculation.
101.DEF**	XBRL Taxonomy Extension Definition.
101.LAB**	XBRL Taxonomy Extension Labels.
101.PRE**	XBRL Taxonomy Extension Presentation.

_______________

* Filed herewith

** Pursuant to Rule 406T of Regulation S-T, these interactive data files are deemed not to be filed or part of a registration statement or prospectus for purposes of Section 11 or 12 of the Securities Act of 1933, as amended, are deemed not filed for purposes of Section 18 of the Securities Act of 1934, as amended, and otherwise not subject to liability under these sections.

27

EX-31.1

Exhibit 31.1

Certifications of Principal Executive Officer

Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, Leonard A. Rosenbaum, certify that:

1. I have reviewed this quarterly report on Form 10-Q of CVD Equipment Corporation;

2. Based upon my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based upon my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f) for the registrant and have:

a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b. Designed such internal controls over financial reporting, or caused such internal controls over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c. Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d. Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrants’ board of directors (or persons performing the equivalent functions):

a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Dated: November 14, 2017

   /s/ Leonard A. Rosenbaum

----------------------------------------

President, Chief Executive Officer and Chairman

EX-31.2

Exhibit 31.2

Certifications of Principal Financial Officer

Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, Glen R. Charles, certify that:

1. I have reviewed this quarterly report on Form 10-Q of CVD Equipment Corporation;

2. Based upon my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based upon my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report.

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f) for the registrant and have:

a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b. Designed such internal controls over financial reporting, or caused such internal controls over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c. Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d. Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrants’ board of directors (or persons performing the equivalent functions):

a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls over financial reporting.

Dated: November 14, 2017

   /s/ Glen R. Charles

----------------------------------------

Chief Financial Officer

EX-32.1

Exhibit 32.1

Certification of Principal Executive Officer

Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to

Section 906 of the Sarbanes-Oxley Act of2002

I, Leonard A. Rosenbaum, President and Chief Executive Officer of CVD Equipment Corporation, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge, the quarterly report on Form 10-Q for the period ending September 30, 2017 of CVD Equipment Corporation (the “Form 10-Q") fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of CVD Equipment Corporation.

Dated: November 14, 2017	/s/  Leonard A. Rosenbaum
	Leonard A. Rosenbaum
	Chief Executive Officer, President and Chairman
	(Principal Executive Officer)

EX-32.2

Exhibit 32.2

Certification of Principal Financial Officer

Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to

Section 906 of the Sarbanes-Oxley Act of 2002

I, Glen R. Charles, Chief Financial Officer of CVD Equipment Corporation, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge, the quarterly report on Form 10-Q for the period ending September 30, 2017 of CVD Equipment Corporation (the “Form 10-Q") fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of CVD Equipment Corporation.

Dated: November 14, 2017	/s/ Glen R. Charles
	Glen R. Charles
	Chief Financial Officer
	(Principal Financial Officer)

XML

Document And Entity Information - shares	9 Months Ended
	Sep. 30, 2017	Nov. 07, 2017
Document Information [Line Items]
Entity Registrant Name	CVD EQUIPMENT CORP
Entity Central Index Key	0000766792
Trading Symbol	cvv
Current Fiscal Year End Date	--12-31
Entity Filer Category	Smaller Reporting Company
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Well-known Seasoned Issuer	No
Entity Common Stock, Shares Outstanding (in shares)		6,409,891
Document Type	10-Q
Document Period End Date	Sep. 30, 2017
Document Fiscal Year Focus	2017
Document Fiscal Period Focus	Q3
Amendment Flag	false

XML

Consolidated Balance Sheets (Current Period Unaudited) - USD ($)	Sep. 30, 2017	Dec. 31, 2016
ASSETS
Cash and cash equivalents	$ 17,180,657	$ 21,677,186
Accounts receivable, net	4,057,354	607,522
Costs and estimated earnings in excess of billings on contracts in progress	4,457,926	2,596,518
Inventories	3,023,009	3,286,539
Other current assets	438,191	235,537
Total Current Assets	29,157,137	28,403,302
Property, plant and equipment, net	13,963,806	14,344,924
Construction in progress	160,263	94,058
Deferred income taxes – non-current	1,881,211	2,440,334
Other assets	415,828	68,450
Intangible assets, net	225,138	253,624
Total Assets	45,803,383	45,604,692
LIABILITIES AND STOCKHOLDERS’ EQUITY
Accounts payable	750,718	743,132
Accrued expenses	2,607,937	1,942,818
Current maturities of long-term debt	300,000	300,000
Billings in excess of costs and estimated earnings on contracts in progress	215,902	5,262,339
Deferred revenue	498,597	77,633
Total Current Liabilities	4,373,154	8,325,922
Long-term debt, net of current portion	2,740,508	2,965,508
Total Liabilities	7,113,662	11,291,430
Stockholders’ Equity
Common stock - $0.01 par value – 20,000,000 shares authorized; issued and outstanding, 6,390,848 at September 30, 2017 and 6,346,590 at December 31, 2016	63,908	63.466
Additional paid-in-capital	24,830,704
Retained earnings	13,795,109	$ 10,118.322
Total Stockholders’ Equity	38,689,721
Total Liabilities and Stockholders’ Equity	$ 45,803,383

XML

Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) - $ / shares	Sep. 30, 2017	Dec. 31, 2016
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, shares authorized (in shares)	20,000,000	20,000,000
Common stock, shares issued (in shares)	6,390,848	6,346,590
Common stock, shares outstanding (in shares)	6,390,848	6,346,590

XML

Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Revenue	$ 10,831,729	$ 4,883,511	$ 31,312,055	$ 13,630,726
Cost of revenue	6,229,062	3,192,345	18,127,799	9,912,207
Gross profit	4,602,667	1,691,166	13,184,256	3,718,519
Operating expenses
Research and development	158,310	150,257	339,610	304,591
Selling and shipping	345,406	261,006	983,731	805,681
General and administrative	2,208,628	1,675,163	6,423,016	5,145,343
Gain on settlement				(628,905)
Total operating expenses	2,712,344	2,086,426	7,746,357	5,626,710
Operating income/(loss)	1,890,323	(395,260)	5,437,899	(1,908,191)
Other income (expense)
Interest income	28,485	7,054	54,538	20,582
Interest expense	(17,189)	(19,153)	(52,433)	(61,608)
Other income	2,575	118,645	3,014	123,093
Total other income	13,871	106,546	5,119	82,067
Income/(loss) before income taxes	1,904,194	(288,714)	5,443,018	(1,826,124)
Income tax expense/(benefit)	508,316	(203,310)	1,766,231	(907,372)
Net income/(loss)	$ 1,395,878	$ (85,404)	$ 3,676,787	$ (918,752)
Basic income/(loss) per common share (in dollars per share)	$ 0.22	$ (0.01)	$ 0.58	$ (0.15)
Diluted income/(loss) per common share (in dollars per share)	$ 0.22	$ (0.01)	$ 0.58	$ (0.15)
Weighted average common shares Outstanding-basic (in shares)	6,378,656	6,323,039	6,314,224	6,269,102
Stock options (in shares)	34,410		33,748
Weighted average common shares Outstanding-diluted (in shares)	6,413,066	6,323,039	6,347,972	6,269,102

XML

Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016
Cash flows from operating activities:
Net income/(loss)	$ 3,676,787	$ (918,752)
Adjustments to reconcile net income/(loss) to net cash provided by operating activities:
Stock-based compensation expense	677,552	544,238
Depreciation and amortization	623,656	618,227
Deferred tax expense/(benefit)	559,123	(836,615)
Provision for doubtful accounts	3,724	39,313
Accounts receivable	(3,453,556)	(4,108,505)
Costs and estimated earnings in excess of billings on contracts in progress	(1,861,408)	1,475,190
Inventories	263,531	(64,328)
Other current assets	(195,073)	(22,669)
Increases/(decreases) in operating liabilities:
Accounts payable and accrued expenses	665,119	(2,251,405)
Current maturities of long-term debt		(280,000)
Billings in excess of costs and estimated earningson contracts in progress	(5,046,437)	9,130,870
Deferred revenue	420,965	(158,031)
Total adjustments	(7,342,804)	4,086,285
Net cash (used in)/provided by operating activities	(3,666,017)	3,167,533
Cash flows from investing activities:
Release of restricted cash		200,000
Capital expenditures	(618,505)	(42,670)
Deposits	(9,127)	1,550
Net cash (used in)/provided by investing activities	(627,632)	158,880
Cash flows from financing activities:
Net proceeds from stock options exercised	22,120	462,000
Payments of long-term debt	(225,000)	(225,000)
Net cash (used in)/provided by financing activities	(202,880)	237,000
Net (decrease)/increase in cash and cash equivalents	(4,496,529)	3,563,413
Cash and cash equivalents at beginning of period	21,677,186	13,073,331
Cash and cash equivalents at end of period	17,180,657	16,636,744
Supplemental disclosure of cash flow information:
Income taxes paid	701,800	101,352
Interest paid	$ 52,433	$ 61,608

XML

Note 1 - Basis of Presentation

9 Months Ended

Sep. 30, 2017

Notes to Financial Statements

Business Description and Basis of Presentation [Text Block]

NOTE

1:

     BASIS OF PRESENTATION

The accompanying unaudited

consolidated financial statements for CVD Equipment Corporation and Subsidiaries (collectively, “the Company”) have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and with the instructions to Form

10

-Q and Article

8

of Regulation S-

X.

They do

not

include all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary in order to make the interim financials

not

misleading have been included and all such adjustments are of a normal recurring nature. The operating results for the

three

and

nine

months ended

September 30, 2017

are

not

necessarily indicative of the results that can be expected for the year ending

December 31, 2017.

The balan

ce sheet as of

December 31, 2016

has been derived from the audited consolidated financial statements at such date, but does

not

include all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements. For further information, please refer to the consolidated financial statements and notes thereto included in the Company’s Annual Report on Form

10

-K for the year ended

December 31, 2016,

filed with the Securities and Exchange Commission on

March 30, 2017,

including the accounting policies followed by the Company as set forth in Note

2

to the consolidated financial statements contained therein.

All material i

ntercompany transactions have been eliminated in consolidation. In addition, certain reclassifications have been made to prior period consolidated financial statements to conform to the current year presentation.

XML

Note 2 - Summary of Significant Accounting Policies

9 Months Ended

Sep. 30, 2017

Notes to Financial Statements

Significant Accounting Policies [Text Block]

NOTE

2:

     SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Revenue Recognition

Revenues from p

roduct and service sales, including those based on time and materials type contracts, are recognized when persuasive evidence of an arrangement exists, product delivery has occurred or services have been rendered, pricing is fixed or determinable, and collection is reasonably assured. Service sales revenues, principally representing repair, maintenance and engineering activities are recognized over the contractual period or as services are rendered.

Revenues from fixed price contracts are recognized on the percentage of completion method, measured on the basis of incurred costs to estimated total costs for each contract. This “cost to cost” method is used because management considers it to be the best available measure of progress on these contracts.

Contract costs include all direct material and labor costs and those indirect costs related to contract performance, such as indirect labor, supplies, tools, repairs and depreciation costs.

Selling, general and administrative costs are charged to expense as incurred. Provisions for estimated losses on contracts

in progress are made in the period in which such losses are determined. Changes in job requirements, job conditions, and estimated profitability, and final contract settlements

may

result in revisions to costs and income and are recognized in the period in which the revisions are determined.

The asset, “Cost

s and estimated earnings in excess of billings on contracts in progress,” represents revenues recognized in excess of amounts billed.

The liability, “Billings in excess of costs and estimated earnings on contracts

in progress,” represents amounts billed in excess of revenues recognized.

Recent Accounting Pronouncements

In

May 2014,

The Financial Accounting Standards Board (“

FASB”) issued Accounting Standards Update (“ASU”)

No.

2014

-

09,

“Revenue from Contracts with Customers” (Topic

606

), which changes the criteria for recognizing revenue. The standard requires an entity which recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The standard requires a

five

-step process for recognizing revenues including identifying the contract with the customer, identifying the performance obligations in the contract, determining the transaction prices, allocating the transaction price to the performance obligations in the contract, and recognizing revenue when (or as) the entity satisfies a performance obligation. Because of the broad scope of this new standard, as it could impact the Company’s contract portfolio and therefore net sales and operating income as well as related business processes, the Company is continuing to perform its detailed review and evaluation of the operational impact of this new ASU including which transition approach to use and the overall effect on its current accounting policies and practices in order to identify potential differences that would result from applying the requirements of the new standard.

The Company

believes there is

no

additional new accounting guidance adopted, but

not

yet effective that is relevant to the readers of its financial statements. However, there are numerous new proposals under development which, if and when enacted,

may

have significant impact on its financial reporting.

XML

Note 3 - Concentration of Credit Risk

9 Months Ended

Sep. 30, 2017

Notes to Financial Statements

Concentration Risk Disclosure [Text Block]

NOTE

3:

     CONCENTRATION OF CREDIT RISK

Cash and cash equivalents

Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash and cash equivalents and accounts receivable. The Company places its cash equivalents with high credit-quality

domestic financial institutions and invests its excess cash primarily in savings accounts and money market instruments. The Company performs periodic evaluations of the relative credit standing of all such institutions as it seeks to maintain stability and liquidity. Cash and cash investments at

September 30, 2017

and

December 31, 2016,

exceeded the Federal Deposit Insurance Corporation (“FDIC”) limits by

$15.6

million and

$20.2

million respectively.

Sales concentration

Revenue to a single customer in any

one

period can exceed

10%

of our total sales. During the

three

months ended

September 30, 2017

and

September 30, 2016,

one

customer represented approximately

59%

and

43%

respectively, of our revenues. During the

nine

months ended

September 30, 2017

and

September 30, 2016

that same customer represented

65%

and

40%

respectively, of our revenues.

Accounts receivable

The Company sells products and services to various companies across several industries in the ordinary course of business. The Company

performs ongoing credit evaluations to assess the probability of accounts receivable collection based on a number of factors, including past transaction experience, evaluation of their credit history and review of the invoicing terms of the contract to determine the financial strength of its customers. The Company also maintains allowances for anticipated losses. One customer represented

23.2%,

another customer represented

14.2%

and a

third

customer represented

10.0%

of the accounts receivable balance at

September 30, 2017.

XML

Note 4 - Contracts in Progress

9 Months Ended

Sep. 30, 2017

Notes to Financial Statements

Long-term Contracts or Programs Disclosure [Text Block]

NOTE

4:

     CONTRACTS IN PROGRESS

Costs and estimated earnings in excess of billings on contracts

in progress are summarized as follows:

	September 30, 2017			December 31, 201 6
Costs incurred on contracts in progress	$	11,557,916		$	4,678,192
Estimated earnings		19,302,951			10,733,826
		30,876,962			15,412,018
Less: Billings to date		26,634,938			(18,077,839	)
Included in accompanying balance sheets under the following captions:	$	4,242,024		$	(2,665,821	)
Costs and estimated earnings in excess of billings on contracts in progress	$	4,457,926		$	2,596,518
Billings in excess of costs and estimated earnings on contracts in progress		(215,902	)		(5,262,339	)
	$	4,242,024		$	(2,665,821	)

XML

Note 5 - Inventories

9 Months Ended

Sep. 30, 2017

Notes to Financial Statements

Inventory Disclosure [Text Block]

NOTE

5:

     INVENTORIES

Inventories

are stated at the lower of cost or net realizable value computed on a

first

-in,

first

-out basis and consist of the following:

	September 30, 2017		December 31, 201 6
Raw materials	$	2,762,009	$	3,062,830
Work-in-process		234,023		159,482
Finished goods		26,977		64,227
Totals	$	3,023,009	$	3,286,539

XML

Note 6 - Accounts Receivable

9 Months Ended

Sep. 30, 2017

Notes to Financial Statements

Allowance for Credit Losses [Text Block]

NOTE

6:

     ACCOUNTS RECEIVABLE

Accounts receivable are presented net of an allowance for doubtful accounts of

approximately

$6,000

and

$2,000

as of

September 30, 2017

and

December 31, 2016,

respectively. The allowance is based on prior experience and management’s evaluation of the collectability of accounts receivable. Management believes the allowance is adequate. However, future estimates

may

change based on changes in future economic conditions.

XML

Note 7 - Debt

9 Months Ended

Sep. 30, 2017

Notes to Financial Statements

Long-term Debt [Text Block]

NOTE

7:

     DEBT

The Company has a revolving credit facility with HSBC Bank, USA, N.A. (“HSBC”) providing up to

$7

million, although the Company has never utilized this facility. This credit facility remains available until

September 1, 2018.

The credit facility also contains certain financial covenants, all of which the Company was in compliance with at

September 30, 2017

and

December 31, 2016.

The Company has a loan agreement with HSBC which is secured by a mortgage against

its Central Islip facility. The loan is payable in

120

consecutive equal monthly installments of principal of

$25,000

plus interest thereon and a final balloon payment upon maturity in

March 2022.

Interest accrues on the loan, at the Company’s option, at the variable rate of LIBOR plus

1.75%

which was

2.99%

and

2.52%

at

September 30, 2017

and

December 31, 2016,

respectively. The principal balances on the mortgage at

September 30, 2017

and

December 31, 2016

were approximately

$3.0

and

$3.3

million, respectively.

XML

Note 8 - Stock-based Compensation Expense

9 Months Ended

Sep. 30, 2017

Notes to Financial Statements

Disclosure of Compensation Related Costs, Share-based Payments [Text Block]

NOTE

8:

     STOCK-BASED COMPENSATION EXPENSE

During the

three

and

nine

months ended

September 30, 2017

and

September 30, 2016,

the Company recorded compensation expense as part of general administrative expense, of

$242,000

and

$198,000

and

$678,000

and

$544,000

respectively, for the cost of employee and director services received in exchange for equity instruments based on the grant-date fair value of those instruments.

XML

Note 9 - Income Taxes

9 Months Ended

Sep. 30, 2017

Notes to Financial Statements

Income Tax Disclosure [Text Block]

NOTE

9

:

     INCOME TAXES

The

provision for income taxes includes the following:

	Nine Months Ended September 30,
	2017		20 16
Current:
Federal	$	1,195,528	$	(71,070	)
State		11,580		314
Total Current income tax provision/(benefit)		1,207,108		(70,756	)
Deferred:
Federal	$	559,123	$	(836,616	)
State		----		---
Total deferred income tax provision/(benefit)		559,123		(836,616	)
Income tax expense/(benefit)	$	1,766,231	$	(907,372	)

Tax Rate Reconciliation

The reconciliation between the Company

’s effective tax rate on income from continuing operations and the statutory rate is as follows:

	Nine Months Ended
	September 30,
	201 7			201 6
Income tax benefit at federal statutory rate [34%]	$	2,075,004		$	(620,882	)
Change in other accruals		90,781			(216,640	)
Difference between tax and book depreciation		(201,847	)		50,213
Stock-based compensation		(197,707	)		(48,993	)
Provision for tax return true up		----			(71,070	)
Income tax expense	$	1,766,231		$	(907,372	)

XML

Note 10 - Earnings Per Share

9 Months Ended

Sep. 30, 2017

Notes to Financial Statements

Earnings Per Share [Text Block]

NOTE

1

0

:

     EARNINGS PER SHARE

B

asic earnings per share are computed by dividing net earnings available to common shareholders (the numerator) by the weighted average number of common shares (the denominator) for the period presented. The computation of diluted earnings per share is similar 

to basic earnings per share, except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potentially dilutive common shares had been issued.

Stock options to purchase

381,930

shares of common stock were outstanding and

196,930

were exercisable during the

three

and

nine

months ended

September 30, 2017.

Stock options to purchase

159,730

shares were outstanding and

79,730

were exercisable during the

three

and

nine

months ended

September 30, 2016.

For the

three

and

nine

months ended

September 30, 2017,

options to purchase

34,410

and

33,748

shares were included in the diluted earnings per share calculation respectively. The balance of stock options outstanding at

September 30, 2017

were

not

included as their effect would have been anti-dilutive. For the

three

and

nine

months ended

September 30, 2016,

none

of the outstanding options were included in the earnings per share calculation as their effect would have been antidilutive.

The potentially dilutive common shares from warrants and options are calculated in accordance with the treasury stock method, which assumes that proceeds from the exercise of all warrants and options are used to repurchase common stock at market value. The amount of shares remaining after the proceeds are exhausted represents the potential dilutive effect of the securities.

XML

Note 11 - Segment Reporting

9 Months Ended

Sep. 30, 2017

Notes to Financial Statements

Segment Reporting Disclosure [Text Block]

N

OTE

11

:

     SEGMENT REPORTING

The

Company operates through

two

(

2

) segments, CVD and SDC. The CVD division, which operates out of Central Islip, New York, is utilized for silicon, silicon germanium, silicon carbide and gallium arsenide processes. SDC is the Company’s ultra-high purity manufacturing division in Saugerties, New York. The respective accounting policies of CVD and SDC are the same as those described in the summary of significant accounting policies (see Note

2

). The Company evaluates performance based on several factors, of which the primary financial measure is income or (loss) before taxes.

Three Months

Ended

September 30,

	CVD			SDC			Eliminations *			Consolidated
201 7
Assets	$	41,615,403		$	5,977,491		$	(1,789,511	)	$	45,803,383
Revenue	$	8,862,726		$	2,548,612		$	(579,609	)	$	10,831,729
Pretax income		1,055,683			848,511						1,904,194
201 6
Assets	$	46,147,895		$	4,316,826		$	(2,960,808	)	$	47,503,913
Revenue	$	4,253,544		$	846,696		$	(216,729	)	$	4,883,511
Pretax income		(180,638	)		(108,076	)					(288,714	)
December 31, 2016
Assets	$	43,300,131		$	4,558,111		$	(2,253,550	)	$	45,604,692

Nine

Months

Ended

September 30,

	CVD			SDC			Eliminations *			Consolidated
2017
Revenue	$	26,847,732		$	6,360,762		$	(1,896,439	)	$	31,312,055
Pretax income		3,403,907			2,039,111						5,443,018
201 6
Revenue	$	11,589,421		$	2,352,384		$	(311,079	)	$	13,630,726
Pretax (loss)		(1,544,278	)		(281,846	)					(1,826,124	)

*All elimination entries represent intersegment revenues eliminated in consolidation f

or external financial reporting.

XML

Note 12 - Subsequent Events

9 Months Ended

Sep. 30, 2017

Notes to Financial Statements

Subsequent Events [Text Block]

Note

12:

SUBSEQUENT EVENTS

On

October 24, 2017,

CVD Equipment Corporation (the “Company”) entered into an Agreement of Purchase and Sale (the “Agreement”) to

purchase a building and real property located at

555

North Research Place, Central Islip, New York

11722

(the “Premises”) from Creative Bath Products, Inc. The purchase price for the Premises is

$13,850,000.00,

exclusive of closing costs (the “Purchase Price”). Upon execution of the Agreement, the Company deposited the sum of

$500,000

into escrow as an initial down payment against the Purchase Price, with the remaining balance of

$13,350,000.00

to be paid at the closing. The acquisition of the Premises and the consummation of the transactions contemplated by the Agreement are contingent upon, among other things, the Company obtaining a commitment from an Institutional Lender (as defined in the Agreement) to make a

first

mortgage loan to the Company of

$10,387,500.00

on such terms and conditions as are specified in the Agreement. The anticipated closing date of the acquisition of the Premises and the transactions contemplated by the Agreement is on or about

January 22, 2018,

or such earlier date as the Company

may

direct upon

three

(

3

) days written notice and is subject to the satisfaction by the parties of customary closing conditions as described in the Agreement.

On

October 31, 2017 (

the “Closing Date”), CVD MesoScribe Technologies Corporation, a New York corporation (“Buyer”) and newly formed and wholly-owned indirect subsidiary of CVD Equipment Corporation (the “Company”) and MesoScribe Technologies, Inc., a Delaware corporation (“Seller”) entered into an Asset Purchase Agreement (the “Asset Purchase Agreement”). Pursuant to the Asset Purchase Agreement, among other things, Buyer acquired (the “Acquisition”) substantially all of the operating assets and business of the Seller (excluding cash, accounts receivable and other specified excluded assets), as more particularly described in the Asset Purchase Agreement.

Pursuant to the Asset Purchase Agreement, the purchase price for the assets acquired in the Acquisition was

$800,000,

of which

$500,000

was paid on the Closing Date and

$300,000

may

be paid to Seller as additional contingent consideration based upon the achievement of certain revenue thresholds and other criteria set forth in the Asset Purchase Agreement with respect to each of the

two

(

2

) consecutive

twelve

(

12

) month measurement periods following the Closing Date.

The Asset Purchase Agreement contains usual and customary representations, warranties and covenants of the parties, as well as indemnification provisions.

XML

Significant Accounting Policies (Policies)

9 Months Ended

Sep. 30, 2017

Accounting Policies [Abstract]

Revenue Recognition, Percentage-of-Completion Method [Policy Text Block]

Revenue Recognition

Revenues from p

roduct and service sales, including those based on time and materials type contracts, are recognized when persuasive evidence of an arrangement exists, product delivery has occurred or services have been rendered, pricing is fixed or determinable, and collection is reasonably assured. Service sales revenues, principally representing repair, maintenance and engineering activities are recognized over the contractual period or as services are rendered.

Revenues from fixed price contracts are recognized on the percentage of completion method, measured on the basis of incurred costs to estimated total costs for each contract. This “cost to cost” method is used because management considers it to be the best available measure of progress on these contracts.

Contract costs include all direct material and labor costs and those indirect costs related to contract performance, such as indirect labor, supplies, tools, repairs and depreciation costs.

Selling, general and administrative costs are charged to expense as incurred. Provisions for estimated losses on contracts

in progress are made in the period in which such losses are determined. Changes in job requirements, job conditions, and estimated profitability, and final contract settlements

may

result in revisions to costs and income and are recognized in the period in which the revisions are determined.

The asset, “Cost

s and estimated earnings in excess of billings on contracts in progress,” represents revenues recognized in excess of amounts billed.

The liability, “Billings in excess of costs and estimated earnings on contracts

in progress,” represents amounts billed in excess of revenues recognized.

New Accounting Pronouncements, Policy [Policy Text Block]

Recent Accounting Pronouncements

In

May 2014,

The Financial Accounting Standards Board (“

FASB”) issued Accounting Standards Update (“ASU”)

No.

2014

-

09,

“Revenue from Contracts with Customers” (Topic

606

), which changes the criteria for recognizing revenue. The standard requires an entity which recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The standard requires a

five

-step process for recognizing revenues including identifying the contract with the customer, identifying the performance obligations in the contract, determining the transaction prices, allocating the transaction price to the performance obligations in the contract, and recognizing revenue when (or as) the entity satisfies a performance obligation. Because of the broad scope of this new standard, as it could impact the Company’s contract portfolio and therefore net sales and operating income as well as related business processes, the Company is continuing to perform its detailed review and evaluation of the operational impact of this new ASU including which transition approach to use and the overall effect on its current accounting policies and practices in order to identify potential differences that would result from applying the requirements of the new standard.

The Company

believes there is

no

additional new accounting guidance adopted, but

not

yet effective that is relevant to the readers of its financial statements. However, there are numerous new proposals under development which, if and when enacted,

may

have significant impact on its financial reporting.

XML

Note 4 - Contracts in Progress (Tables)

9 Months Ended

Sep. 30, 2017

Notes Tables

Schedule Of Cost And Estimated Earnings In Excess Of Billings [Table Text Block]

	September 30, 2017			December 31, 201 6
Costs incurred on contracts in progress	$	11,557,916		$	4,678,192
Estimated earnings		19,302,951			10,733,826
		30,876,962			15,412,018
Less: Billings to date		26,634,938			(18,077,839	)
Included in accompanying balance sheets under the following captions:	$	4,242,024		$	(2,665,821	)
Costs and estimated earnings in excess of billings on contracts in progress	$	4,457,926		$	2,596,518
Billings in excess of costs and estimated earnings on contracts in progress		(215,902	)		(5,262,339	)
	$	4,242,024		$	(2,665,821	)

XML

Note 5 - Inventories (Tables)

9 Months Ended

Sep. 30, 2017

Notes Tables

Schedule of Inventory, Current [Table Text Block]

	September 30, 2017		December 31, 201 6
Raw materials	$	2,762,009	$	3,062,830
Work-in-process		234,023		159,482
Finished goods		26,977		64,227
Totals	$	3,023,009	$	3,286,539

XML

Note 9 - Income Taxes (Tables)

9 Months Ended

Sep. 30, 2017

Notes Tables

Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]

	Nine Months Ended September 30,
	2017		20 16
Current:
Federal	$	1,195,528	$	(71,070	)
State		11,580		314
Total Current income tax provision/(benefit)		1,207,108		(70,756	)
Deferred:
Federal	$	559,123	$	(836,616	)
State		----		---
Total deferred income tax provision/(benefit)		559,123		(836,616	)
Income tax expense/(benefit)	$	1,766,231	$	(907,372	)

Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]

	Nine Months Ended
	September 30,
	201 7			201 6
Income tax benefit at federal statutory rate [34%]	$	2,075,004		$	(620,882	)
Change in other accruals		90,781			(216,640	)
Difference between tax and book depreciation		(201,847	)		50,213
Stock-based compensation		(197,707	)		(48,993	)
Provision for tax return true up		----			(71,070	)
Income tax expense	$	1,766,231		$	(907,372	)

XML

Note 11 - Segment Reporting (Tables)

9 Months Ended

Sep. 30, 2017

Notes Tables

Schedule of Segment Reporting Information, by Segment [Table Text Block]

	CVD			SDC			Eliminations *			Consolidated
201 7
Assets	$	41,615,403		$	5,977,491		$	(1,789,511	)	$	45,803,383
Revenue	$	8,862,726		$	2,548,612		$	(579,609	)	$	10,831,729
Pretax income		1,055,683			848,511						1,904,194
201 6
Assets	$	46,147,895		$	4,316,826		$	(2,960,808	)	$	47,503,913
Revenue	$	4,253,544		$	846,696		$	(216,729	)	$	4,883,511
Pretax income		(180,638	)		(108,076	)					(288,714	)
December 31, 2016
Assets	$	43,300,131		$	4,558,111		$	(2,253,550	)	$	45,604,692

	CVD			SDC			Eliminations *			Consolidated
2017
Revenue	$	26,847,732		$	6,360,762		$	(1,896,439	)	$	31,312,055
Pretax income		3,403,907			2,039,111						5,443,018
201 6
Revenue	$	11,589,421		$	2,352,384		$	(311,079	)	$	13,630,726
Pretax (loss)		(1,544,278	)		(281,846	)					(1,826,124	)

XML

Note 3 - Concentration of Credit Risk (Details Textual) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016	Dec. 31, 2016
Cash, Uninsured Amount	$ 15.6		$ 15.6		$ 20.2
One Customer [Member] | Customer Concentration Risk [Member] | Sales Revenue, Net [Member]
Concentration Risk, Percentage	59.00%	43.00%	65.00%	40.00%
One Customer [Member] | Customer Concentration Risk [Member] | Accounts Receivable [Member]
Concentration Risk, Percentage			23.20%
Customer Two [Member] | Customer Concentration Risk [Member] | Accounts Receivable [Member]
Concentration Risk, Percentage			14.20%
Customer Three [Member] | Customer Concentration Risk [Member] | Accounts Receivable [Member]
Concentration Risk, Percentage			10.00%

XML

Note 4 - Contracts in Progress - Costs, Estimated Earnings, and Billings on Uncompleted Contracts (Details) - USD ($)	Sep. 30, 2017	Dec. 31, 2016
Costs incurred on contracts in progress	$ 11,557,916	$ 4,678,192
Estimated earnings	19,302,951	10,733,826
Total	30,876,962	15,412,018
Less: Billings to date	26,634,938	18,077,839
Less: Billings to date	(26,634,938)	(18,077,839)
Included in accompanying balance sheets under the following captions:	4,242,024	(2,665,821)
Costs and estimated earnings in excess of billings on contracts in progress	4,457,926	2,596,518
Billings in excess of costs and estimated earnings on contracts in progress	(215,902)	(5,262,339)
Cost in excess of billing, net	$ 4,242,024	$ (2,665,821)

XML

Note 5 - Inventories - Components of Inventories (Details) - USD ($)	Sep. 30, 2017	Dec. 31, 2016
Raw materials	$ 2,762,009	$ 3,062,830
Work-in-process	234,023	159,482
Finished goods	26,977	64,227
Totals	$ 3,023,009	$ 3,286,539

XML

Note 6 - Accounts Receivable (Details Textual) - USD ($)	Sep. 30, 2017	Dec. 31, 2016
Allowance for Doubtful Accounts Receivable, Current	$ 6,000	$ 2,000

XML

Note 7 - Debt (Details Textual)	9 Months Ended
	Sep. 30, 2017 USD ($)	Dec. 31, 2016 USD ($)
HSBC Bank Mortgage Loan [Member] | HSBC Bank [Member]
Debt Instrument, Number of Payments	120
Debt Instrument, Periodic Payment	$ 25,000
Debt Instrument, Interest Rate, Effective Percentage	2.99%	2.52%
Long-term Debt	$ 3,000,000	$ 3,300,000
HSBC Bank Mortgage Loan [Member] | HSBC Bank [Member] | London Interbank Offered Rate (LIBOR) [Member]
Debt Instrument, Basis Spread on Variable Rate	1.75%
HSBC Bank [Member] | Revolving Credit Facility [Member]
Line of Credit Facility, Maximum Borrowing Capacity	$ 7,000,000

XML

Note 8 - Stock-based Compensation Expense (Details Textual) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Allocated Share-based Compensation Expense	$ 242,000	$ 198,000	$ 678,000	$ 544,000

XML

Note 9 - Income Taxes - Components of Income Taxes (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Current:
Federal			$ 1,195,528	$ (71,070)
State			11,580	314
Total Current income tax provision/(benefit)			1,207,108	(70,756)
Deferred:
Federal			559,123	(836,616)
State
Total deferred income tax provision/(benefit)			559,123	(836,615)
Income tax expense/(benefit)	$ 508,316	$ (203,310)	$ 1,766,231	$ (907,372)

XML

Note 9 - Income Taxes - Effective Income Tax Rate Reconciliation (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Income tax benefit at federal statutory rate [34%]			$ 2,075,004	$ (620,882)
Change in other accruals			90,781	(216,640)
Difference between tax and book depreciation			(201,847)	50,213
Stock-based compensation			(197,707)	(48,993)
Provision for tax return true up				(71,070)
Income tax expense/(benefit)	$ 508,316	$ (203,310)	$ 1,766,231	$ (907,372)

XML

Note 9 - Income Taxes - Effective Income Tax Rate Reconciliation (Details) (Parentheticals)	9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016
Federal statutory rate	34.00%	34.00%

XML

Note 10 - Earnings Per Share (Details Textual) - shares	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number	381,930	159,730	381,930	159,730
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number	196,930	79,730	196,930	79,730
Employee Stock Option [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	34,410	0	33,748	0

XML

Note 11 - Segment Reporting (Details Textual)	9 Months Ended
	Sep. 30, 2017
Number of Operating Segments	2

XML

Note 11 - Segment Reporting - Segment Information (Details) - USD ($)		3 Months Ended		9 Months Ended
		Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016	Dec. 31, 2016
Assets		$ 45,803,383	$ 47,503,913	$ 45,803,383	$ 47,503,913	$ 45,604,692
Revenue		10,831,729	4,883,511	31,312,055	13,630,726
Pretax income		1,904,194	(288,714)	5,443,018	(1,826,124)
Intersegment Eliminations [Member]
Assets	[1]	(1,789,511)	(2,960,808)	(1,789,511)	(2,960,808)	(2,253,550)
Revenue	[1]	(579,609)	(216,729)	(1,896,439)	(311,079)
Pretax income	[1]
CVD [Member] | Operating Segments [Member]
Assets		41,615,403	46,147,895	41,615,403	46,147,895	43,300,131
Revenue		8,862,726	4,253,544	26,847,732	11,589,421
Pretax income		1,055,683	(180,638)	3,403,907	(1,544,278)
SDC [Member] | Operating Segments [Member]
Assets		5,977,491	4,316,826	5,977,491	4,316,826	$ 4,558,111
Revenue		2,548,612	846,696	6,360,762	2,352,384
Pretax income		$ 848,511	$ (108,076)	$ 2,039,111	$ (281,846)

[1] All elimination entries represent intersegment revenues eliminated in consolidation for external financial reporting.

XML

Note 12 - Subsequent Events (Details Textual) - USD ($)				9 Months Ended
	Jan. 22, 2018	Oct. 31, 2017	Oct. 24, 2017	Sep. 30, 2017	Sep. 30, 2016
Payments to Acquire Property, Plant, and Equipment				$ 618,505	$ 42,670
Creative Bath Products, Inc [Member] | Scenario, Forecast [Member]
Payments to Acquire Property, Plant, and Equipment	$ 13,350,000
Lenders [Member] | Scenario, Forecast [Member]
Debt Instrument, Face Amount	$ 10,387,500
Subsequent Event [Member] | Creative Bath Products, Inc [Member]
Purchase Commitment, Amount			$ 13,850,000
Escrow Deposit			$ 500,000
Subsequent Event [Member] | MesoScribe Technologies, Inc [Member]
Purchase Commitment, Amount		$ 800,000
Payments to Acquire Productive Assets		500,000
Purchase Commitment, Contingent Consideration Amount		$ 300,000